Found 63 matching trials
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment NA Pilot Immunotherapy Study of Combination Prostate Specific Membrane Antigen...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute
Learn More & Join Trial
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients PHASE1 The incidence of melanoma is increasing with an estimated incidence of 59,9...
Show More Location
New York University Langone Medical Center
Learn More & Join Trial
Personalized Neoantigen Peptide Vaccines for Solid Tumors PHASE1 This clinical trial is studying the safety and efficacy of a personalized c...
Show More Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Learn More & Join Trial
Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC PHASE2 The overall purpose of this research study is to find a better way to treat...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC PHASE2 The goal of this clinical trial is as follows:(1) Establish a clinical tech...
Show More Location
Second Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) PHASE2 The purpose of this study is to test the safety of a course of injections c...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) PHASE1 The purpose of this study is to determine whether the combination of a neoa...
Show More Location
Johns Hopkins SKCCC
Learn More & Join Trial
DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia PHASE1 This phase I trial studies the side effects and immune response to DEC-205/...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC PHASE1 This is a single institution, Phase 1 study for patients with Stage III/IV ...
Show More Location
Johns Hopkins University
Learn More & Join Trial
Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity PHASE2 This is a multi-center, randomized, double-blind clinical trial to assess t...
Show More Location
University of Maryland Greenebaum Cancer Center
Learn More & Join Trial